Predictions for Targeted Drug Delivery with David Elder and Brendan Griffin

Andrea Charles

In this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how they are tackling major challenges in drug development, such as improving solubility to enhance bioavailability and overcoming poor compound stability. They also share their thoughts on the latest developments in micro and nanoparticle technology and how can they be used for targeted dr...
To continue reading this story get free access